---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-078226"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2024-03-27T23:59:59+00:00"
generated_at: "2026-06-04T07:07:48.974276+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics receives Nasdaq delisting notices; plans to appeal

## Summary
- March 21 notice: failed to meet $50M MVLS and $1.00 bid price for 30 consecutive days.
- March 26 notice: failed to meet $15M market value of publicly held shares requirement.
- Company will request hearings by March 28 and April 2 deadlines; stay pending outcome.
- May request transfer to Nasdaq Capital Market; no guarantee of approval or continued listing.
- Common stock (GRTX) expected to remain listed at least until Panel decision.

## SEC filing metadata
- accession: 0001193125-24-078226
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2024-03-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312524078226/0001193125-24-078226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312524078226/d797057d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-078226
- JSON: https://secwatch.observer/filing/0001193125-24-078226.json
- Plain text: https://secwatch.observer/filing/0001193125-24-078226.txt

## Key facts
- Listing & Compliance Notices
  Galera Therapeutics, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A), 5450(b)(2)(C)
  source text: March 26, 2024, the Company received a letter from the Staff indicating that the Company has not regained compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 required for continued listing on The Nasdaq Global Market as set forth in Nasdaq Listing Rule 5450(b)(2)(C) (the “Minimum MVPHS Requirement”), and that, unless the Company requests a hearing before a Panel to appeal Nasdaq’s delisting determination by 4:00 p.m. Eastern Time on April 2, 2024, trading of the Company’s common stock will be suspended at the opening of business on April 3, 2024, and the C
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312524078226/0001193125-24-078226-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.